175 related articles for article (PubMed ID: 25175912)
1. Self-directedness: an indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression.
Baeken C; Desmyter S; Duprat R; De Raedt R; Van Denabbeele D; Tandt H; Lemmens GM; Vervaet M; van Heeringen K
Psychiatry Res; 2014 Dec; 220(1-2):269-74. PubMed ID: 25175912
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.
Baeken C; Marinazzo D; Everaert H; Wu GR; Van Hove C; Audenaert K; Goethals I; De Vos F; Peremans K; De Raedt R
Brain Stimul; 2015; 8(4):808-15. PubMed ID: 25744500
[TBL] [Abstract][Full Text] [Related]
3. Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression.
Siddiqi SH; Chockalingam R; Cloninger CR; Lenze EJ; Cristancho P
J Psychiatr Pract; 2016 May; 22(3):193-202. PubMed ID: 27123799
[TBL] [Abstract][Full Text] [Related]
4. The impact of one HF-rTMS session on mood and salivary cortisol in treatment resistant unipolar melancholic depressed patients.
Baeken C; De Raedt R; Leyman L; Schiettecatte J; Kaufman L; Poppe K; Vanderhasselt MA; Anckaert E; Bossuyt A
J Affect Disord; 2009 Feb; 113(1-2):100-8. PubMed ID: 18571733
[TBL] [Abstract][Full Text] [Related]
5. Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients.
Baeken C; Vanderhasselt MA; Remue J; Herremans S; Vanderbruggen N; Zeeuws D; Santermans L; De Raedt R
J Affect Disord; 2013 Nov; 151(2):625-631. PubMed ID: 23896317
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
7. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
8. HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression.
Baeken C; De Raedt R; Santermans L; Zeeuws D; Vanderhasselt MA; Meers M; Vanderbruggen N
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):684-7. PubMed ID: 20307619
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
[TBL] [Abstract][Full Text] [Related]
10. HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging.
Baeken C; De Raedt R; Van Hove C; Clerinx P; De Mey J; Bossuyt A
CNS Spectr; 2009 Aug; 14(8):439-48. PubMed ID: 19890238
[TBL] [Abstract][Full Text] [Related]
11. The impact of accelerated high frequency rTMS on brain neurochemicals in treatment-resistant depression: Insights from
Baeken C; Lefaucheur JP; Van Schuerbeek P
Clin Neurophysiol; 2017 Sep; 128(9):1664-1672. PubMed ID: 28738276
[TBL] [Abstract][Full Text] [Related]
12. Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?
Wu GR; Baeken C
Brain Imaging Behav; 2017 Feb; 11(1):8-16. PubMed ID: 26780241
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
[TBL] [Abstract][Full Text] [Related]
14. Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity.
Baeken C; Marinazzo D; Wu GR; Van Schuerbeek P; De Mey J; Marchetti I; Vanderhasselt MA; Remue J; Luypaert R; De Raedt R
World J Biol Psychiatry; 2014 May; 15(4):286-97. PubMed ID: 24447053
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptom trajectories associated with standard and accelerated rTMS.
Kaster TS; Chen L; Daskalakis ZJ; Hoy KE; Blumberger DM; Fitzgerald PB
Brain Stimul; 2020; 13(3):850-857. PubMed ID: 32289716
[TBL] [Abstract][Full Text] [Related]
16. Are there clinical and neurophysiologic predictive factors for a positive response to HF-rTMS in patients with treatment-resistant depression?
Poleszczyk A; Rakowicz M; Parnowski T; Antczak J; Święcicki Ł
Psychiatry Res; 2018 Jun; 264():175-181. PubMed ID: 29649674
[TBL] [Abstract][Full Text] [Related]
17. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.
Pallanti S; Di Rollo A; Antonini S; Cauli G; Hollander E; Quercioli L
Neuropsychobiology; 2012 Jun; 65(4):227-35. PubMed ID: 22653158
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation.
Lepping P; Schönfeldt-Lecuona C; Sambhi RS; Lanka SV; Lane S; Whittington R; Leucht S; Poole R
Acta Psychiatr Scand; 2014 Nov; 130(5):326-41. PubMed ID: 24724996
[TBL] [Abstract][Full Text] [Related]
19. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
Pelissolo A; Corruble E
Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
[TBL] [Abstract][Full Text] [Related]
20. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
Ciobanu C; Girard M; Marin B; Labrunie A; Malauzat D
J Affect Disord; 2013 Sep; 150(2):677-81. PubMed ID: 23673085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
